Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on April 7, 2020, covering the event date of April 1, 2020. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "GH".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the departure of a director from the Board of Directors.
- Director Departure: Dipchand Nishar informed the Company on April 1, 2020, that he will not stand for re-election to the Board of Directors when his term expires at the 2020 Annual Meeting of Stockholders.
- Reason for Departure: Mr. Nishar stated his decision is not due to any dispute or disagreement with the Company. Instead, it is in response to his increased responsibilities regarding SoftBank Vision Fund portfolio companies in light of the COVID-19 pandemic.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the context of the director's departure related to the COVID-19 pandemic.
Key Facts for Investor Verification
- Confirm the date of the 2020 Annual Meeting of Stockholders to determine the exact timing of Mr. Nishar's departure.
- Verify if the Board has nominated a replacement candidate for the upcoming annual meeting.
- Review subsequent filings for any impact on the Company's strategic direction or SoftBank Vision Fund relationship.